Showing results (311-320 of 657) with videos related to
Sort By:
Pageof 66
The Lancet. Microbe|July 29, 2026
Tecovirimat treatment of clade II mpox: a virological analysis of a randomised, double-blind, phase 3 trialDariia Vyshenska, Jonathan C Reed, Pavitra Roychoudhury, et al.The Lancet. Microbe|July 29, 2026
Advances in development of tuberculosis vaccines and preventive drug therapies: current pipeline, evidence, and accessChristopher da Costa, Ben J Marais, Delia Goletti, et al.The Lancet. Microbe|August 1, 2026
Minimal supply chain and forecasting testing volumes for clinical bacteriology laboratories in resource-limited settings for individual patient care: a costing studyMakeda Semret, Olumide Ajibola, Barbara Barbé, et al.The Lancet. Microbe|August 24, 2026
Profiling the dynamics of maternally acquired and infection-induced antibodies against influenza B in early childhood: a longitudinal paired mother-infant cohort study from southern ChinaZeyao Zhao, Junbo Chen, Chao Han, et al.The Lancet. Microbe|September 9, 2026
Bacterial co-detection in individuals with acute respiratory infections through a direct-to-consumer platform in China: a retrospective cross-sectional studyChunyan Xiang, Jingya Li, Mengwei Yan, et al.The Lancet. Microbe|September 15, 2026
Assessing SARS-CoV-2 immune markers in vaccinated asymptomatic adults after household exposure in Canada (AB-PROTECT): a prospective cohort studyChristopher Kandel, Jessica A Breznik, Maureen Taylor, et al.The Lancet. Microbe|September 5, 2026
Five decades of pneumococcal meningitis in Spain: a single-centre, clinical and genomic, retrospective, observational studySara Calvo-Silveria, Aida González-Díaz, Carmen Cabellos, et al.The Lancet. Microbe|September 30, 2026
A competitive BB-ELISA for anti-toxin B neutralising antibodies in assessing risk of recurrent Clostridioides difficile infection: a retrospective cohort study from the MODIFY I and II trialsHua Yu, Eugénie Bassères, Rachel Lee, et al.The Lancet. Microbe|September 15, 2026
COVID-19 vaccine effectiveness in people on immunosuppressive therapies: a systematic review and meta-analysisEva Stadler, Shanchita R Khan, Karen M Elias, et al.The Lancet. Microbe|September 15, 2026
Investigating the role of a non-synonymous mutation at dhfr codon 50 in maintaining sulphadoxine-pyrimethamine resistance in Plasmodium falciparum: a modelling studyCarola J Salas, Nessma Adil Mahmoud Yousif, Stephen E Lizewski, et al.Pageof 66